Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies

Kyriakidis, I; Vasileiou, E; Rossig, C; Roilides, E; Groll, AH; Tragiannidis, A

Tragiannidis, A (corresponding author), Aristotle Univ Thessaloniki, AHEPA Hosp, Pediat & Adolescent Hematol Oncol Unit, Fac Hlth Sci,Sch Med,Dept Pediat 2, Thessaloniki 54636, Greece.; Tragiannidis, A (corresponding author), Univ Childrens Hosp Munster, Ctr Bone Marrow Transplantat, D-48149 Munster, Germany.; Tragiannidis, A (corresponding author), Univ Childrens Hosp Munster, Infect Dis Res Program, Dept Pediat Hematol & Oncol, D-48149 Munster, Germany.

JOURNAL OF FUNGI, 2021; 7 (3):

Abstract

Since 1985 when the first agent targeting antigens on the surface of lymphocytes was approved (muromonab-CD3), a multitude of such therapies have been......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索